References
- Ifudu O, Paul HR, Homel P, et al. Predictive value of functional status for mortality in patients on maintenance hemodialysis. Am J Nephrol. 1998;18(2):109–116.
- McClellan WM, Anson C, Birkeli K, et al. Functional status and quality of life: predictors of early mortality among patients entering treatment for end stage renal disease. J Clin Epidemiol. 1991;44(1):83–89.
- Arogundade FA, Zayed B, Daba M, et al. Correlation between Karnofsky performance status scale and short-form health survey in patients on maintenance hemodialysis. J Natl Med Assoc. 2004;96(12):1661–1667.
- Johansen KL, Dalrymple LS, Delgado C, et al. Association between body composition and frailty among prevalent hemodialysis patients: a US Renal Data System special study. JASN. 2014;25(2):381–389.
- Johansen KL, Dalrymple LS, Delgado C, et al. Comparison of self-report-based and physical performance-based frailty definitions among patients receiving maintenance hemodialysis. Am J Kidney Dis. 2014;64(4):600–607.
- Johansen KL, Dalrymple LS, Delgado C, et al. Factors associated with frailty and its trajectory among patients on hemodialysis. Clin J Am Soc Nephrol. 2017;12(7):1100–1108.
- Shimoda T, Matsuzawa R, Yoneki K, et al. Changes in physical activity and risk of all-cause mortality in patients on maintence hemodialysis: a retrospective cohort study. BMC Nephrol. 2017;18(1):154.
- Chen JB, Lee WC, Cheng BC, et al. Impact of risk factors on functional status in maintenance hemodialysis patients. Eur J Med Res. 2017;22(1):54.
- Lai YC, Wang CY, Moi SH, et al. Factors associated with functional performance among patients on hemodialysis in Taiwan. Blood Purif. 2018;46(1):12–18.
- Block GA, Klassen PS, Lazarus JM, et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15(8):2208–2218.
- Slinin Y, Foley RN, Collins AJ. Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study. JASN. 2005;16(6):1788–1793.
- Beddhu S, Kimmel PL, Ramkumar N, et al. Associations of metabolic syndrome with inflammation in CKD: results From the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis. 2005;46(4):577–586.
- Sun Y, Jiang L, Shao X. Predictive value of procalcitonin for diagnosis of infections in patients with chronic kidney disease: a comparison with traditional inflammatory markers C-reactive protein, white blood cell count, and neutrophil percentage. Int Urol Nephrol. 2017;49(12):2205–2216.
- Iyasere OU, Brown EA, Johansson L, et al. Quality of life and physical function in older patients on dialysis: a comparison of assisted peritoneal dialysis with hemodialysis. Clin J Am Soc Nephrol. 2016;11(3):423–30.
- Ng JK, Kwan BC, Chow KM, et al. Frailty in Chinese peritoneal dialysis patients: prevalence and prognostic significance. Kidney Blood Press Res. 2016;41(6):736–745.
- Mor V, Laliberte L, Morris JN, et al. The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting. Cancer. 1984;53(9):2002–2007.
- Zhu JG, Chen JB, Cheng BC, et al. Association between extreme values of markers of chronic kidney disease: mineral and bone disorder and 5-year mortality among prevalent hemodialysis patients. Blood Purif. 2018;45(1-3):1–7.
- Murtagh FE, Addington-Hall JM, Higginson IJ. End-stage renal disease: a new trajectory of functional decline in the last year of life. J Am Geriatr Soc. 2011;59(2):304–308.
- Oishi D, Koitabashi K, Hiraki K, et al. Physical activity is associated with serum albumin in peritoneal dialysis patients. Adv Perit Dial. 2012;28:148–152.
- Cupisti A, D'Alessandro C, Fumagalli G, et al. Nutrition and physical activity in CKD patients. Kidney Blood Press Res. 2014;39(2-3):107–113.
- Cobo G, Gallar P, Gama-Axelsson T, et al. Clinical determinants of reduced physical activity in hemodialysis and peritoneal dialysis patients. J Nephrol. 2015;28(4):503–510.
- Giorgetti S, Raimondi S, Cassinelli S, et al. beta2-Microglobulin is potentially neurotoxic, but the blood brain barrier is likely to protect the brain from its toxicity. Nephrol Dial Transplant. 2009;24(4):1176–1181.
- Relini A, Canale C, De Stefano S, et al. Collagen plays an active role in the aggregation of beta2-microglobulin under physiopathological conditions of dialysis-related amyloidosis. J Biol Chem. 2006;281(24):16521–16529.
- Relini A, De Stefano S, Torrassa S, et al. Heparin strongly enhances the formation of beta2-microglobulin amyloid fibrils in the presence of type I collagen. J Biol Chem. 2008;283(8):4912–4920.